When you absolutely have to recruit patients on time.

Home 5 Our Locations

BUILD A DIVERSE TRIAL GEOGRAPHY FOR IMPROVED PERFORMANCE

Uniquely positioned in an attractive region for conducting multinational, multicenter clinical trials, we offer you local clinical staff in each country, directed by our strong and responsive central project management. Diversifying the clinical trial locations can be a part of a successful recruitment and retention strategy. Our region offers hundreds of clinical sites, all compliant with global industry standards. Accell’ robust, across-the-board Standard Operating Procedures ensure compliance to the full extent across all operating geographies.

Clinical trials approval in 30-60 days

On average, it takes a total between 4 and 5 months for Accell’s team to start-up a trial. Regulatory assessment is always a part of our strategy.

Regulatory agency recognition

About 60% of clinical trial data included in MA applications to the EMA has been generated outside the EU. We work in EU countries, as well as non-EU countries fully compliant with ICH E6 Guidelines.

Patient access

We offer unparalleled access to centralized and specialized healthcare and sites with high treatment capacity. This allows trial sponsors to recruit 6-10 times faster than at sites set in a private practice.

Strategic thinking

Our country selection approach revolves around building strong relationships with hundreds of centralized, multidepartment hospitals in various indications. Stringent investigator selection criteria help ensure our projections are met.

Our Locations

• The US has 1 clinical trial for every 3,000 people.
• Russia has 1 clinical trial for every 38,000 people.

Map of All Studies on ClinicalTrials.gov


discover our region country by country


Belarus

Non-EU
60 days for regulatory approval
9.5 million population

Bulgaria

EU
60 days for regulatory approval
7.1 million population

Croatia

EU
60 days for regulatory approval
4.1 million population

Estonia

EU
60 days for regulatory approval
1.3 million population

Georgia

Non-EU
28-56 days for regulatory approval
3.7 million population

Hungary

EU
60 days for regulatory approval
9.8 million population

Kazakhstan

Non-EU
10 business days for regulatory approval | 17.8 million population

Latvia

EU
60 days for regulatory approval
1.96 million population

Lithuania

EU
60 days for regulatory approval
2.8 million population

Montenegro

EU
60 days for regulatory approval
622 781 population

Poland

EU
75 days for regulatory approval
37.95 million population

Romania

EU
60 days for regulatory approval
19.71 million population

Russia

Non-EU
60 days for regulatory approval
144.3 million population

Serbia

EU
60 days for regulatory approval
7 million population

Ukraine

Non-EU
60 days for regulatory approval
45 million population

This Is Your Team. We Make Clinical Trials Happen.